Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
After decades of pioneering work, our revolutionary platform launched. With our platform, scientists have the ability to precisely deposit epigenetic changes in a locus-specific manner, enabling manipulation of cell phenotype for therapeutic purpose.
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy
Along with your contribution, we are committed to benefiting patients with wide variety
